Small intestinal cancer: A population-based study of incidence and survival patterns in the United States, 1992 to 2006

Cancer Epidemiology Biomarkers and Prevention

Volumn 19, Issue 8, 2010, Pages 1908-1918

  Qubaiah, Osama ^a,b   Devesa, Susan S ^c   Platz, Charles E ^d   Huycke, Mark M ^a,b   Dores, Graça M ^a,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; ASIAN; CANCER GRADING; CANCER INCIDENCE; CANCER SURVIVAL; CAUCASIAN; FEMALE; GROUPS BY AGE; HISTOPATHOLOGY; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE DISEASE; PACIFIC ISLANDER; PRIORITY JOURNAL; RACE DIFFERENCE; SARCOMA; SEX DIFFERENCE; SMALL INTESTINE CANCER; SMALL INTESTINE CARCINOMA; UNITED STATES;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CARCINOMA; CONTINENTAL POPULATION GROUPS; FEMALE; HUMANS; INCIDENCE; INTESTINAL NEOPLASMS; INTESTINE, SMALL; LYMPHOMA; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; RISK FACTORS; SARCOMA; SEX FACTORS; SURVIVAL RATE; UNITED STATES; YOUNG ADULT;

EID: 77955460895     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-0328     Document Type: Article

References (43)

1. Gabos S, Berkel J, Band P, Robson D, Whittaker H. Small bowel cancer in western Canada. Int J Epidemiol 1993;22:198-206. (Pubitemid 23129319)
2. Neugut AI, Jacobson JS, Suh S, Mukherjee R, Arber N. The epidemiology of cancer of the small bowel. Cancer Epidemiol Biomarkers Prev 1998;7:243-51.
3. Neugut AI, Santos J. The association between cancers of the small and large bowel. Cancer Epidemiol Biomarkers Prev 1993; 2:551-3.
4. Schottenfeld D, Beebe-Dimmer JL, Vigneau FD. The epidemiology and pathogenesis of neoplasia in the small intestine. Ann Epidemiol 2009;19:58-69.
5. Bilimoria KY, Bentrem DJ, Wayne JD, et al. Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg 2009;249:63-71.
6. Chow JS, Chen CC, Ahsan H, Neugut AI. A population-based study of the incidence of malignant small bowel tumours: SEER, 1973-1990. Int J Epidemiol 1996;25:722-8.
7. Gustafsson BI, Siddique L, Chan A, et al. Uncommon cancers of the small intestine, appendix and colon: an analysis of SEER 1973-2004, and current diagnosis and therapy. Int J Oncol 2008;33: 1121-31.
8. Haselkorn T, Whittemore AS, Lilienfeld DE. Incidence of small bowel cancer in the United States and worldwide: geographic, temporal, and racial differences. Cancer Causes Control 2005;16:781-7. (Pubitemid 41160042)
9. Lepage C, Bouvier AM, Manfredi S, Dancourt V, Faivre J. Incidence and management of primary malignant small bowel cancers: a well-defined French population study. Am J Gastroenterol 2006;101: 2826-32. (Pubitemid 44902657)
10. Severson RK, Schenk M, Gurney JG, Weiss LK, Demers RY. Increasing incidence of adenocarcinomas and carcinoid tumors of the small intestine in adults. Cancer Epidemiol Biomarkers Prev 1996;5:81-4.
11. Shack LG, Wood HE, Kang JY, et al. Small intestinal cancer in England & Wales and Scotland: time trends in incidence, mortality and survival. Aliment Pharmacol Ther 2006;23:1297-306.
12. Thomas RM, Sobin LH. Gastrointestinal cancer. Cancer 1995;75: 154-70.
13. Percy C, VanHolten V, Muir C, editors. International Classification of Diseases for Oncology. Geneva (Switzerland): World Health Organization; 1990.
14. Stang A, Stegmaier C, Eisinger B, et al. Descriptive epidemiology of small intestinal malignancies: the German Cancer Registry experience. Br J Cancer 1999;80:1440-4.
15. Ross RK, Hartnett NM, Bernstein L, Henderson BE. Epidemiology of adenocarcinomas of the small intestine: is bile a small bowel carcinogen? Br J Cancer 1991;63:143-5.
16. Pashayan N, Lepage C, Rachet B, Woods LM, Coleman MP. Survival trends for small intestinal cancer in England and Wales, 1971-1990: national population-based study. Br J Cancer 2006;95:1296-300.
17. Surveillance, Epidemiology and End Results (SEER) Program (http:// www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER-12 Regs Public-Use, Nov 2008 Sub (1992-2006), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2009, based on the November 2008 submission.
18. Fritz A, Percy C, Jack A, et al, editors. International Classification of Diseases for Oncology. Geneva (Switzerland): World Health Organization; 2000.
19. Ries LAG, Horner MJD, Young JL, Jr. Introduction. In: Ries LAG, Young JL, Jr., Keel GE, Eisner MP, Lin YD, Horner MJ, editors. Cancer Survival Among Adults: U.S. SEER Program, 1988-2001. Bethesda: National Cancer Institute, NIH Publ. No. 07-6215; 2007, p. 1-6.
20. Young JL, Jr., Roffers SD, Ries LAG, Fritz AG, Hurlbut AA, editors. SEER Summary Staging Manual-2000; Codes and Coding Instructions. Bethesda: National Cancer Institute, NIH Pub. No. 01-4969; 2001.
21. Key C, Meisner ALW. Cancers of the esophagus, stomach, and small intestine. In: Ries LAG, Young JL, Jr., Keel GE, Eisner MP, Lin YD, Horner MJ, editors. Cancer Survival Among Adults: U.S. SEER Program, 1988-2001. Bethesda: National Cancer Institute, NIH Publ. No. 07-6215; 2007, p. 23-32.
22. Devesa SS, Donaldson J, Fears T. Graphical presentation of trends in rates. Am J Epidemiol 1995;141:300-4.
23. In: Horner MJ, Ries LAG, Krapcho M, et al, editors. SEER Cancer Statistics Review, 1975-2006. Bethesda (MD): National Cancer Institute; 2009.
24. Stolzenberg-Solomon RZ, Fraumeni JF, Jr., Wideroff L, Albanes D, Curtis RE. New malignanices following cancer of the digestive tract, excluding colorectal cancer. In: Curtis RE, Freedman DM, Ron E, Ries LAG, Hacker DG, Edwards BK, Tucker MA, Fraumeni JF, Jr., editors. New malignancies among cancer survivors: SEER cancer registries, 1973-2000. Bethesda: National Cancer Institute, NIH Publ. No. 05-5302; 2006, p. 59-110.
25. Cook MB, Dawsey SM, Freedman ND, et al. Sex disparities in cancer incidence by period and age. Cancer Epidemiol Biomarkers Prev 2009;18:1174-82.
26. Yao JC, Hassan M, Phan A, et al. One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 2008;26: 3063-72.
27. Newton JN, Swerdlow AJ, dos Santos Silva IM, et al. The epidemiology of carcinoid tumours in England and Scotland. Br J Cancer 1994;70:939-42.
28. Thompson GB, van Heerden JA, Martin JK, Jr., et al. Carcinoid tumors of the gastrointestinal tract: presentation, management, and prognosis. Surgery 1985;98:1054-63.
29. Kloppel G, Anlauf M. Epidemiology, tumour biology and histopathological classification of neuroendocrine tumours of the gastrointestinal tract. Best Pract Res Clin Gastroenterol 2005;19:507-17. (Pubitemid 41447715)
30. Besson C, Goubar A, Gabarre J, et al. Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood 2001;98:2339-44.
31. Kirk O, Pedersen C, Cozzi-Lepri A, et al. Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy. Blood 2001;98:3406-12.
32. Lim ST, Karim R, Nathwani BN, et al. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy. J Clin Oncol 2005; 23:4430-8.
33. Morton LM, Wang SS, Devesa SS, et al. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 2006; 107:265-76.
34. Zucca E, Bertoni F, Roggero E, Cavalli F. The gastric marginal zone B-cell lymphoma of MALT type. Blood 2000;96:410-9. (Pubitemid 30463357)
35. Ferreri AJ, Guidoboni M, Ponzoni M, et al. Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. J Natl Cancer Inst 2004;96:586-94.
36. Lecuit M, Abachin E, Martin A, et al. Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N Engl J Med 2004;350:239-48.
37. Parsonnet J, Isaacson PG. Bacterial infection and MALT lymphoma. N Engl J Med 2004;350:213-5.
38. Di Sabatino A, Corazza GR. Coeliac disease. Lancet 2009;373: 1480-93.
39. Rondonotti E, Pennazio M, Toth E, et al. Small-bowel neoplasms in patients undergoing video capsule endoscopy: a multicenter European study. Endoscopy 2008;40:488-95. (Pubitemid 351911838)
40. Demetri GD, von Mehren M, Blanke CD, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002;347:472-80.
41. Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002;346:235-42. (Pubitemid 34438862)
42. Pfreundschuh M, Trumper L, Osterborg A, et al. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol 2006;7:379-91.
43. Overman MJ, Varadhachary GR, Kopetz S, et al. Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater. J Clin Oncol 2009;27: 2598-603.